Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas T Fearon

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 25, 2012
Maintenance of T cell function in the face of chronic antigen stimulation and repeated reactivation for a latent virus infectionLaura K Mackay, Linda Wakim, Catherine J van Vliet, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2025
Signal peptide-independent secretion of keratin-19 by pancreatic cancer cellsPhilip Moresco, Jonathan P Kastan, Jung-In Yang, et al.
Science (New York, N.Y.)|May 19, 2018
Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastasesArnaud Pommier, Naishitha Anaparthy, Nicoletta Memos, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2022
Carcinomas assemble a filamentous CXCL12-keratin-19 coating that suppresses T cell-mediated immune attackZhikai Wang, Philip Moresco, Ran Yan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2005
BCL6b mediates the enhanced magnitude of the secondary response of memory CD8+ T lymphocytesPeter M Manders, Patricia J Hunter, Aino I Telaranta, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2018
Fenofibrate prevents skeletal muscle loss in mice with lung cancerMarcus D Goncalves, Seo-Kyoung Hwang, Chantal Pauli, et al.
The Journal of Experimental Medicine|July 16, 2020
Cancer cell CCR2 orchestrates suppression of the adaptive immune responseMiriam R Fein, Xue-Yan He, Ana S Almeida, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2013
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancerChristine Feig, James O Jones, Matthew Kraman, et al.
JCI Insight|September 26, 2023
Plasma cells in human pancreatic ductal adenocarcinoma secrete antibodies against self-antigensMin Yao, Jonathan Preall, Johannes T-H Yeh, et al.
Cancer Immunology Research|April 3, 2016
De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research InstituteIra Mellman, Vanessa M Hubbard-Lucey, Matthew J Tontonoz, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|January 25, 2012
Maintenance of T cell function in the face of chronic antigen stimulation and repeated reactivation for a latent virus infectionLaura K Mackay, Linda Wakim, Catherine J van Vliet, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2025
Signal peptide-independent secretion of keratin-19 by pancreatic cancer cellsPhilip Moresco, Jonathan P Kastan, Jung-In Yang, et al.
Science (New York, N.Y.)|May 19, 2018
Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastasesArnaud Pommier, Naishitha Anaparthy, Nicoletta Memos, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2022
Carcinomas assemble a filamentous CXCL12-keratin-19 coating that suppresses T cell-mediated immune attackZhikai Wang, Philip Moresco, Ran Yan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2005
BCL6b mediates the enhanced magnitude of the secondary response of memory CD8+ T lymphocytesPeter M Manders, Patricia J Hunter, Aino I Telaranta, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2018
Fenofibrate prevents skeletal muscle loss in mice with lung cancerMarcus D Goncalves, Seo-Kyoung Hwang, Chantal Pauli, et al.
The Journal of Experimental Medicine|July 16, 2020
Cancer cell CCR2 orchestrates suppression of the adaptive immune responseMiriam R Fein, Xue-Yan He, Ana S Almeida, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2013
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancerChristine Feig, James O Jones, Matthew Kraman, et al.
JCI Insight|September 26, 2023
Plasma cells in human pancreatic ductal adenocarcinoma secrete antibodies against self-antigensMin Yao, Jonathan Preall, Johannes T-H Yeh, et al.
Cancer Immunology Research|April 3, 2016
De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research InstituteIra Mellman, Vanessa M Hubbard-Lucey, Matthew J Tontonoz, et al.
Pageof 6